John F. Neylan

2017

In 2017, John F. Neylan earned a total compensation of $1.3M as Chief Medical Officer at Keryx Biopharmaceuticals, a 25% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$161,257
Option Awards$386,042
Salary$428,047
Stock Awards$269,588
Other$6,192
Total$1,251,126

Neylan received $428K in salary, accounting for 34% of the total pay in 2017.

Neylan also received $161.3K in non-equity incentive plan, $386K in option awards, $269.6K in stock awards and $6.2K in other compensation.

Rankings

In 2017, John F. Neylan's compensation ranked 7,903rd out of 14,666 executives tracked by ExecPay. In other words, Neylan earned more than 46.1% of executives.

ClassificationRankingPercentile
All
7,903
out of 14,666
46th
Division
Manufacturing
2,964
out of 5,768
49th
Major group
Chemicals And Allied Products
967
out of 2,074
53rd
Industry group
Drugs
753
out of 1,730
57th
Industry
Pharmaceutical Preparations
590
out of 1,329
56th
Source: SEC filing on May 31, 2018.

Neylan's colleagues

We found four more compensation records of executives who worked with John F. Neylan at Keryx Biopharmaceuticals in 2017.

2017

Gregory Madison

Keryx Biopharmaceuticals

Chief Executive Officer

2017

Christine Carberry

Keryx Biopharmaceuticals

Chief Operating Officer

2017

Scott Holmes

Keryx Biopharmaceuticals

Chief Financial Officer

2017

Brian Adams

Keryx Biopharmaceuticals

General Counsel

You may also like